Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.
about
Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapyThe influence of tumor size and environment on gene expression in commonly used human tumor linesNanoparticle delivery enhancement with acoustically activated microbubbles.Real-time visualization and quantitation of vascular permeability in vivo: implications for drug deliveryThe potential of polymeric micelles in the context of glioblastoma therapy.Advanced 3D-Sonographic Imaging as a Precise Technique to Evaluate Tumor Volume.Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.Normalization of the vasculature for treatment of cancer and other diseases.Ultrasound-enhanced drug transport and distribution in the brain.Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.Margination of micro- and nano-particles in blood flow and its effect on drug delivery.Enhanced tumor targeting by an intratumoral injection of colloidal chromic 32P in two human tumors (AsPC-1 pancreas and Ls174T colon) in nude mice.Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation.Image-guided convection-enhanced delivery platform in the treatment of neurological diseases.In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour.Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.Changing the pathophysiology of solid tumours: the potential of TNF and other vasoactive agents.Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.HPMA copolymers: origins, early developments, present, and future.Frontiers in cancer nanomedicine: directing mass transport through biological barriersEffects of cellular pharmacology on drug distribution in tissues.Photochemical internalization of tumor-targeted protein toxins.Agile delivery of protein therapeutics to CNSMeasurement of mass transport and reaction parameters in bulk solution using photobleaching. Reaction limited binding regimeEffect of cell arrangement and interstitial volume fraction on the diffusivity of monoclonal antibodies in tissueQuantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications.Current views on the function of the lymphatic vasculature in health and diseaseMulti-stage delivery nano-particle systems for therapeutic applicationsDirect measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleachingBiological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiationGenetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells.Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapyConvection-enhanced delivery of macromolecules in the brain.Solid tumor therapy: manipulation of the vasculature with TNF.Clinical value of the assessment of gynaecological tumour angiogenesis by transvaginal colour Doppler.Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents.Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanomaVEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.Tumour angiogenesis, vascular biology and enhanced drug delivery.
P2860
Q24655930-B3A4A9DE-EFC5-423E-A94F-D75DD4A378D7Q24795105-76406E09-FDED-41B2-A24B-B7311B1F3723Q26866082-9CE16F61-C80B-44EE-8E4C-0A8B67424BAFQ27306235-55EBF4BC-23D9-4155-B536-60B981481C82Q27693205-5C554DBC-1FB8-4981-8C08-3FB4DDB78E08Q30418829-9E717AC8-2B31-4099-AD9D-9B958C1E9EA2Q30442799-D7D2C368-CCE0-4414-B4AE-313B53B1B23AQ30469815-C24EB100-D8AC-47AC-91C2-37F887FD3B80Q30471456-E5DA61A9-FD19-4C4C-AE51-9B39AEDAFEF1Q30478731-6D1CEA05-6819-456B-A621-1DD33681564CQ30542073-566F4D4A-3A7D-43BE-8CD2-B4544476BFE6Q30577405-C497EABC-AD3E-400D-AF51-20D2046EA371Q30658677-3B60DC9A-D9D0-4076-9D68-6F55C08EB111Q30986337-8AFAA891-0E24-4BF7-A9A7-5CDE76490034Q31141544-99AB21BE-3376-4403-8200-C23053691336Q33178931-FA94A7D0-5B56-49B9-AC58-4838058013ABQ33183860-D2C396F4-F7DA-4C62-9138-66C8C8F8F5A1Q33245795-A01FF5FB-3E9B-4E60-A12F-0D87811ED0CCQ33325343-1EE00FFA-93DD-423A-B91F-4EA9D6A1D52DQ33719148-8AC2BD31-94C7-4C4D-B9D0-7ABFDBBDFBECQ33746335-7F84ECE1-1C69-4F51-A8D5-F9730AAF95DAQ34047139-5B02732B-AF1E-4EE3-903C-54EBE7663F54Q34068201-1FCD628B-F49D-458F-AE6A-7A57CF3FFAB3Q34079647-10506D5A-F276-4121-BBAA-651B2B5DD40EQ34087888-A09F8343-802B-44F7-AF20-DBEFE1FC9147Q34092522-52BD66B9-A851-4411-90E4-D39E83080312Q34126535-A0AA7827-57D0-4B3D-B4B0-89CA4C46FBADQ34164880-05EBB60F-F15B-4421-BC1F-AE99EA151E89Q34166491-67149023-3A8E-40BC-B3A0-2FD567746AF1Q34290518-1641DF75-4DA5-4CD3-AD33-B8FE08DEBB05Q34405013-C728A892-05DC-469A-BDC8-087384704BCEQ34451877-52866A42-C772-4D4F-8A74-9EB4283CC356Q34743875-31905E64-6AA8-4F6D-BF54-07A6A9D86ED5Q35091232-BD9DB743-797D-4017-AE43-76C6AFE93403Q35142322-DD278F71-76F7-47CA-95C6-ACD7020B3034Q35323588-27378840-A213-455B-BD07-7CF0B9D6B1F2Q35663759-DD2885D0-03C8-4E22-A15D-C2C10EFA2C84Q35746804-A45A86BE-3511-442B-B4B4-3B34DA929A1BQ35786920-C6170160-1377-43ED-B14A-08272D07A77CQ35931998-7332960D-18BA-4C4C-AAB8-5DBD2AAA65B8
P2860
Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.
@en
type
label
Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.
@en
prefLabel
Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.
@en
P356
P1476
Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.
@en
P2093
P304
P356
10.1093/JNCI/81.8.570
P407
P577
1989-04-01T00:00:00Z